Anar al contingut (clic a Intro)
UdG Home UdG Home
Tancar
Menú

Dra.  Peracaula Miro, Rosa

Plana personal

Categoria
PROFESSORA TITULAR D'UNIVERSITAT
Departament
BIOLOGIA
Àrea de coneixement
BIOQUÍMICA I BIOLOGIA MOLECULAR
Grup de recerca
Bioquímica del Càncer

Currículum abreujat

Rosa Peracaula Miró

Associate Professor and co-director of the research group Biochemistry of Cancer (GRCT003) at the University of Girona

Biochemistry and Molecular Biology Unit. Biology Department, Faculty of Sciences. University of Girona. 17071 Girona, Spain.

Phone: +00 (34) 972 418 370

E-mail: rosa.peracaula@udg.edu

ORCID: 0000-0003-3513-524X

Member of SEBBM (Sociedad Española de Bioquímica y Biología Molecular) and ASEICA (Asociación Española de Investigación contra el Cáncer)

Research lines:

- Tumor markers: Altered glycosylation of serum proteins as potential tumor markers.  Focused on pancreatic adenocarcinoma and prostate cancer, in particular human pancreatic ribonuclease and acute-phase proteins in pancreatic cancer and prostate specific antigen (PSA) in prostate cancer. Extended to other glycoproteins (proteomics and glycomics)

 - Molecular mechanisms for the glycosylation changes in cancer: Studies on glycosyltransferase expression, their involvement in tumor progression steps and the factors that regulate their expression. Inhibition of sialyltransferases to reduce cancer hypersialylation.

 

Projects (last 10 years):

- “Altered glycosylation in pancreatic cancer: Basis to develop novel biomarkers and therapeutic targets (GLYCOPAC)”. MICINN. PID2020-115686RB-I00.  09/2021- 09/2024. IP: Drs. Rosa Peracaula/Esther Llop.

- Non-invasive biomarkers for Prostate Cancer clinical risk stratification: PSA glycoforms and multiparametric magnetic resonance imaging. Predictive model for potential metastasic Prostate Cancer. Fundació La Marató de TV3, ref. 201922. 19/07/2020-19/07/2022. IP: Drs. E. Llop (University of Girona) and J. Comet (IdIbGi).

- Influencia de la glicosilación alterada en cáncer de  páncreas. Estrategias glicoproteómicas para la búsqueda de nuevos marcadores tumorales. MINECO BIO2015-66356-R. - 01/2016- 12/2018. IP: Rosa Peracaula/Rafael de LLorens 

Grupo de investigación consolidado: Bioquímica y Clínica del Cáncer. Generalitat de Catalunya. V Pla de Recerca de Catalunya. Ref. SGR 2017-673. 2017- 2021. IP: Rafael de Llorens

Grupo de investigación consolidado: Bioquímica y Clínica del Cáncer. Generalitat de Catalunya. IV Pla de Recerca de Catalunya. Ref. SGR 2014-229. 2014 - 2017. IP: Rafael de Llorens

Glicosilación alterada en cáncer: Glicoproteínas y glicosiltransferasas en suero y tejidos como marcadores tumorales. MICINN (Gobierno de España)-Ref. BIO2010-16922. 2011-2013.  IP: Rosa Peracaula Miró

Grupo de investigación consolidado. Generalitat de Catalunya. III Pla de Recerca de Catalunya. Ref. 2009SGR-717. 2009 - 2012. IP: Rafael de Llorens

Mecanismo de resistencia tumoral a través de la vía EGFR. Universidad de Girona. 2008. IP: Rafael de Llorens

Altered glycosylation in tumours: Potential use of serum glycoproteins as tumour markers. MCIIN (Gobierno de España)-Ref. BIO2007-61323. 2007-2010. IP: Rosa Peracaula Miró

Thematic cooperative research nets in medicine. Thematic research net in cancer. Instituto de Salud Carlos III. 2007-2010. IP: Ramon Colomer

Role of Glycosyltransferases in the invasive and metastatic potential of pancreatic adenocarcinoma. Ref: (050932, 2005).  Fundació La Marató. 2006-2009. IP: Rosa Peracaula Miró

Grupo de investigación consolidado. Generalitat de Catalunya. II Pla de Recerca de Catalunya. Ref. SGR 2005-00065. 2006-2009. IP: Rafael de Llorens

Aberrant glycosylation of serum proteins as tumour markers. MCYT (Gobierno de España)-Ref. BIO2004-00438. 2004-2007. IP: Rosa Peracaula Miró

 

Publications (last 10 years): 

- Esther Llop and Rosa Peracaula. "Lectin Affinity Chromatography for the Discovery of Novel Cancer Glycobiomarkers: A Case Study with PSA Glycoforms and Prostate Cancer" (Chapter 15).  Methods in Molecular Biology 2022, Vol. 2370: Glycosylation, Methods and Protocols, pp. 301-313. Gavin Davey (Eds). Springer.  ISBN: 978-1-0716-1684-0.

- Greville G, Llop E, Howard J, Madden SF, Perry AS, Peracaula R, Rudd PM, McCann A, Saldova R.  5-AZA-dC induces epigenetic changes associated with modified glycosylation of secreted glycoproteins and increased EMT and migration in chemo-sensitive cancer cells. Clin Epigenetics. 2021, 13(1):34. doi: 10.1186/s13148-021-01015-7

- Gratacós-Mulleras A, Duran A, Asadi Shehni A, Ferrer-Batallé M, Ramírez M, Comet J, de Llorens R, Saldova R, Llop E, Peracaula R. Characterisation of the main PSA glycoforms in aggressive prostate cancer. Scientific Reports 2020, 10(1):18974. doi: 10.1038/s41598-020-75526-3.

-Greville G, Llop E, Huang C, Creagh-Flynn J, Pfister S, O'Flaherty R, Madden SF, Peracaula R, Rudd PM, McCann A, Saldova R. Hypoxia Alters Epigenetic and N-Glycosylation Profiles of Ovarian and Breast Cancer Cell Lines in-vitro. Front Oncol. 2020, 10:1218. doi: 10.3389/fonc.2020.01218. eCollection 2020.

- Guerrero PE, Miró L, Wong BS, Massaguer A, Martínez-Bosch N, Llorens R, Navarro P, Konstantopoulos K, Llop E, Peracaula R. Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion. Int J Mol Sci. 2020 Aug 28;21(17):6239. doi: 10.3390/ijms21176239.

- Guerrero PE, Duran A, Ortiz MR, Castro E, Garcia-Velasco A, Llop E, Peracaula R. Microfibril associated protein 4 (MFAP4) is a carrier of the tumor associated carbohydrate sialyl-Lewis x (sLex) in pancreatic adenocarcinoma. J Proteomics. 2020;231:104004. doi: 10.1016/j.jprot.2020.104004.

- Mancera-Arteu M, Giménez E, Balmaña M, Barrabés S, Albiol-Quer M, Fort E, Peracaula R, Sanz-Nebot V. Multivariate data analysis for the detection of human alpha-acid glycoprotein aberrant glycosylation in pancreatic ductal adenocarcinoma. J Proteomics. 2019; 195:76-87. doi: 10.1016/j.jprot.2019.01.006

- Balmaña M, Duran A, Gomes C, Llop E, López-Martos R, Ortiz MR, Barrabés S, Reis CA, Peracaula R. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues. Int J Biol Macromol. 2018;112:33-45. doi: 10.1016/j.ijbiomac.2018.01.148.

- Llop E, E Guerrero P, Duran A, Barrabés S, Massaguer A, José Ferri M, Albiol-Quer M, de Llorens R, Peracaula R. Glycoprotein biomarkers for the detection of pancreatic ductal adenocarcinoma. World J Gastroenterol. 2018;24:2537-2554.

- Mancera-Arteu M, Giménez E, Barbosa J, Peracaula R, Sanz-Nebot V. Zwitterionic-hydrophilic interaction capillary liquid chromatography coupled to tandem mass spectrometry for the characterization of human alpha-acid-glycoprotein N-glycan isomers. Anal Chim Acta. 2017;991:76-88. doi: 10.1016/j.aca.2017.07.068

- Ferrer-Batallé M, Llop E, Ramírez M, Aleixandre RN, Saez M, Comet J, de Llorens R, Peracaula R. Comparative Study of Blood-Based Biomarkers, α2,3-Sialic Acid PSA and PHI, for High-Risk Prostate Cancer Detection. Int J Mol Sci. 2017;18(4). pii: E845. doi: 10.3390/ijms18040845.

-Barrabés S, Llop E, Ferrer-Batallé M, Ramírez M, Aleixandre RN, Perry AS, de Llorens R, Peracaula R. Analysis of urinary PSA glycosylation is not indicative of high-risk prostate cancer. Clin Chim Acta 2017, 470:97-102. doi: 10.1016/j.cca.2017.05.009

- Barrabés S, Farina-Gomez N, Llop E, Puerta A, Diez-Masa JC, Perry A, de Llorens R, de Frutos M, Peracaula R. Comparative analysis of prostate-specific antigen by two-dimensional gel electrophoresis and capillary electrophoresis. Electrophoresis. 2016 Oct 2. doi: 10.1002/elps.201600432

- Llop E, Ferrer-Batallé M, Barrabés S, Guerrero PE, Ramírez M, Saldova R, Rudd PM, Aleixandre RN, Comet J, de Llorens R, Peracaula R. Improvement of Prostate Cancer Diagnosis by Detecting PSA Glycosylation-Specific Changes. Theranostics 2016;6(8):1190-204.

- Ferri MJ, Saez M, Figueras J, Fort E, Sabat M, López-Ben S, de Llorens R, Aleixandre RN, Peracaula R. Improved Pancreatic Adenocarcinoma Diagnosis in Jaundiced and Non-Jaundiced Pancreatic Adenocarcinoma Patients through the Combination of Routine Clinical Markers Associated to Pancreatic Adenocarcinoma Pathophysiology. PLoS One. 2016;11(1):e0147214.

- Balmaña M, Giménez E, Puerta A, Llop E, Figueras J, Fort E, Sanz-Nebot V, de Bolós C, Rizzi A, Barrabés S, de Frutos M, Peracaula R. Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer. J Proteomics. 2016;132:144-54. 

- Bassagañas S, Allende H, Cobler L, Ortiz MR, Llop E, de Bolós C, Peracaula R. Inflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell lines. Cytokine. 2015;75(1):197-206. doi: 10.1016/j.cyto.2015.04.006.

- Giménez E, Balmaña M, Figueras J, Fort E, de Bolós C, Sanz-Nebot V, Peracaula R, Rizzi A. Quantitative analysis of N-glycans from human alfa-acid-glycoprotein using stable isotope labeling and zwitterionic hydrophilic interaction capillary liquid chromatography electrospray mass spectrometry as tool for pancreatic disease diagnosis. Anal Chim Acta. 2015;866:59-68. doi: 10.1016/j.aca.2015.02.008.

- Balmaña M, Sarrats A, Llop E, Barrabés S, Saldova R, Ferri MJ, Figueras J, Fort E, de Llorens R, Rudd PM, Peracaula R. Identification of potential pancreatic cancer serum markers: Increased sialyl-Lewis X on ceruloplasmin. Clin Chim Acta. 2015;442:56-62. doi: 10.1016/j.cca.2015.01.007.

- Bassagañas S, Carvalho S, Dias AM, Pérez-Garay M, Ortiz MR, Figueras J, Reis CA, Pinho SS, Peracaula R. Pancreatic cancer cell glycosylation regulates cell adhesion and invasion through the modulation of α2β1 integrin and E-cadherin function. PLoS One. 2014;9(5):e98595. doi:10.1371/journal.pone.0098595.

- Saldova R, Piccard H, Pérez-Garay M, Harvey DJ, Struwe WB, Galligan MC, Berghmans N, Madden SF, Peracaula R, Opdenakker G, Rudd PM. Increase in sialylation and branching in the mouse serum N-glycome correlates with inflammation and ovarian tumour progression. PLoS One. 2013 ;8(8):e71159. doi: 10.1371/journal.pone.0071159.

- Bassagañas S, Pérez-Garay M, Peracaula R. Cell surface sialic acid modulates extracellular matrix adhesion and migration in pancreatic adenocarcinoma cells. Pancreas. 2014;43(1):109-17. doi: 10.1097/MPA.0b013e31829d9090.

- Pérez-Garay M, Arteta B, Llop E, Cobler L, Pagès L, Ortiz R, Ferri MJ, de Bolós C, Figueras J, de Llorens R, Vidal-Vanaclocha F, Peracaula R. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues. Int J Biochem Cell Biol. 2013;45(8):1748-57. doi: 10.1016/j.biocel.2013.05.015.

- Saldova R, Dempsey E, Pérez-Garay M, Mariño K, Watson JA, Blanco-Fernández A, Struwe WB, Harvey DJ, Madden SF, Peracaula R, McCann A, Rudd PM. 5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer. Epigenetics. 2011 Nov 1;6(11).

- Padró M, Mejías-Luque R, Cobler L, Garrido M, Pérez-Garay M, Puig S, Peracaula R, de Bolós C. Regulation of glycosyltransferases and Lewis antigens expression by IL-1ß and IL-6 in human gastric cancer cells. Glycoconj J. 2011 ;28(2):99-110

- Sarrats A, Saldova R, Pla E, Fort E, Harvey DJ, Struwe WB, de Llorens R, Rudd PM, Peracaula R. Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis. Proteomics Clin Appl. 2010 ;4(4):432-48. doi: 10.1002/prca.200900150.

- Peracaula R, Sarrats A, Rudd PM Liver proteins as sensor of human malignancies and inflammation. Proteomics Clin Appl. 2010 ;4(4):426-31. doi: 10.1002/prca.200900170.

- Pérez-Garay M, Arteta B, Pagès L, de Llorens R, de Bolòs C, Vidal-Vanaclocha F, Peracaula R. alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo. PLoS One. 2010 ;5(9). pii: e12524.

- Sarrats A, Saldova R, Comet J, O'Donoghue N, de Llorens R, Rudd PM, Peracaula R. Glycan characterization of PSA 2-DE subforms from serum and seminal plasma. OMICS. 2010;14(4):465-74.

- Barrabés S, Sarrats A, Fort E, De Llorens R, Rudd PM, Peracaula R. Effect of sialic acid content on glycoprotein pI analyzed by two-dimensional electrophoresis. Electrophoresis. 2010;31(17):2903-12.

- Sarrats A, Comet J, Tabarés G, Ramírez M, Aleixandre RN, de Llorens R, Peracaula R. Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis. Prostate. 2010 ;70(1):1-9.

- Peracaula R, Barrabés S, Sarrats A, Rudd PM, de Llorens R. Altered glycosylation in tumours focused to cancer diagnosis. Dis Markers. 2008;25(4-5):207-18. Review.

- Tabarés G, Jung K, Reiche J, Stephan C, Lein M, Peracaula R, de Llorens R, Hoesel W. Free PSA forms in prostatic tissue and sera of prostate cancer patients: analysis by 2-DE and western blotting of immunopurified samples. Clin Biochem. 2007 ;40(5-6):343-50.

- Barrabés S, Pagès-Pons L, Radcliffe CM, Tabarés G, Fort E, Royle L, Harvey DJ, Moenner M, Dwek RA, Rudd PM, De Llorens R, Peracaula R. Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. Glycobiology. 2007 ;17(4):388-400.

- Tabarés G, Radcliffe CM, Barrabés S, Ramírez M, Aleixandre RN, Hoesel W, Dwek RA, Rudd PM, Peracaula R, de Llorens R. Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology. 2006 ;16(2):132-45.

- Peracaula R, Tabarés G, López-Ferrer A, Brossmer R, de Bolós C, de Llorens R. Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells. Glycoconj J. 2005 ;22(3):135-44.

- Peracaula R, Royle L, Tabares G, Mallorqui-Fernández G, Barrabés S, Harvey DJ, Dwek RA, Rudd PM, de Llorens R. Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states. Glycobiology. 2003;13(4):227-44.

- Peracaula R, Tabarés G, Royle L, Harvey DJ, Dwek RA, Rudd PM, de Llorens R. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology. 2003 ;13(6):457-70.

- Pous J, Mallorquí-Fernández G, Peracaula R, Terzyan SS, Futami J, Tada H, Yamada H, Seno M, de Llorens R, Gomis-Rüth FX, Coll M. Three-dimensional structure of human RNase 1 delta N7 at 1.9 A resolution. Acta Crystallogr D Biol Crystallogr. 2001 ;57(Pt 4):498-505.

- Peracaula R, Cleary KR, Lorenzo J, de Llorens R, Frazier ML. Human pancreatic ribonuclease 1: expression and distribution in pancreatic adenocarcinoma. Cancer. 2000;89(6):1252-8.

- Mallorquí-Fernández G, Pous J, Peracaula R, Aymamí J, Maeda T, Tada H, Yamada H, Seno M, de Llorens R, Gomis-Rüth FX, Coll M. Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution. J Mol Biol. 2000;300(5):1297-307.

- Fernández-Salas E, Peracaula R, Frazier ML, de Llorens R. Ribonucleases expressed by human pancreatic adenocarcinoma cell lines. Eur J Biochem. 2000 ;267(5):1484-94.

- Terzyan SS, Peracaula R, de Llorens R, Tsushima Y, Yamada H, Seno M, Gomis-Rüth FX, Coll M. The three-dimensional structure of human RNase 4, unliganded and complexed with d(Up), reveals the basis for its uridine selectivity. J Mol Biol. 1999 ;285(1):205-14.

Patents:

- Óscar Pozo, Àlex Gomez, Gabriel Gil, Manuel Pera, Laura Visa, Edurne Arriola, Rosa Peracaula, Esther Llop, Ernesto Castro, Adelaida Garcia, Esther Fort, Dúnia Pérez. “Method for diagnosing cancer”. EP22382244.6. 14.03.2022. Fundació Institut Mar d’Investigacions Mèdiques (IMIM), Univ. de Girona/Fundació Institut d’Investigació Biomèdica de Girona Dr.Josep Trueta, Institut Català d’Oncologia..

-R. Peracaula, R de Llorens, E. Llop, M. Ferrer-Batallé, S. Barrabés, J. Comet, RN. Aleixandre, M. Ramírez, PM Rudd, R. Saldova. “Método in vitro para el diagnóstico del cáncer de próstata” PCT/ES2016/070781 06.11.2015. Univ. de Girona/Fundació Institut d’Investigació Biomèdica de Girona Dr.Josep Trueta.

- R. Peracaula, MJ. Ferri, M. Saez, J, Figueras, RN, Aleixandre, R de Llorens. “Combinatoria de los marcadores clínicos CA19.9, CEA, IGF-1 y albúmina que mejoran el diagnóstico del cáncer de páncreas frente la pancreatitis crònica”. PCT/ES2015/070529. 08.07.2014. Univ. de Girona/Hospital Josep Trueta.

- Rudd, P.M Dwek R.A.; Treacy, M. ; O'Driscoll, K., De Llorens R., Peracaula R.Glycosylation Markers for Cancer and Chronic Inflammation”. PCT/GB2008/050607. USA. 21.07.2008. Universidad de Oxford/NIBRT-University College Dublin/Universidad de Girona.

-Dwek R.A.; De Llorens R., Peracaula R., Radcliffe C.M.; Royle L.;Rudd, P.M.; Zitzmann N. Glycosylation markers for cancer diagnosing and monitoring PCT/IB2005/002531. USA. 24.06.2005. Universidad de Oxford/Universidad de Girona.

Escull quins tipus de galetes acceptes que el web de la Universitat de Girona pugui guardar en el teu navegador.

Les imprescindibles per facilitar la vostra connexió. No hi ha opció d'inhabilitar-les, atès que són les necessàries pel funcionament del lloc web.

Permeten recordar les vostres opcions (per exemple llengua o regió des de la qual accediu), per tal de proporcionar-vos serveis avançats.

Proporcionen informació estadística i permeten millorar els serveis. Utilitzem cookies de Google Analytics que podeu desactivar instal·lant-vos aquest plugin.

Per a oferir continguts publicitaris relacionats amb els interessos de l'usuari, bé directament, bé per mitjà de tercers (“adservers”). Cal activar-les si vols veure els vídeos de Youtube incrustats en el web de la Universitat de Girona.